DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Radioligand
Radioligand
Test–Retest Variability of Serotonin 5-HT2A Receptor Binding Measured with Positron Emission Tomography and [18F]Altanserin in the Human Brain
Current Status and Growth of Nuclear Theranostics in Singapore
Download
In Vivo Molecular Imaging: Ligand Development and Research Applications
[18F] Altanserin Bolus Injection in the Canine Brain Using PET Imaging
Altanserin and [18F]Deuteroaltanserin for PET
Tracking Down the Antimigraine Effect of Triptans; the Relationship Between 5-HT1B Receptors in the Vasculature and Parenchyma Mentor 1 Gitte Moos Knudsen
A Picture of Modern Tc-99M Radiopharmaceuticals: Production, Chemistry, and Applications in Molecular Imaging
PET Radiotracers for CNS-Adrenergic Receptors: Developments and Perspectives
Trends in Radiopharmaceuticals
Evaluation of the Superselective Radioligand [ I]PE2I for Imaging of the Dopamine Transporter in SPECT
Wx Reduced Binding of F Altanserin to Serotonin Type 2A Receptors in Aging
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
Chapter 2 Technetium in Medicine 2
Radiation Dosimetry Of
Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
Biodistribution and Radiation Dosimetry of the Serotonin Transporter Ligand 11C-DASB Determined from Human Whole-Body PET
Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients
Top View
A PET Study with [11C]CIMBI-36 and D-Amphetamine Challenge
Development of Novel Pet Radioligands for Visualizing Beta Cell Mass and Amyloid Plaques
(5-HT1A) Receptor Antag
11C-Mcn5652 and 11C-DASB As Serotonin Transporter Radioligands Under Various Experimental Conditions
12 Pharmacological Prerequisites for PET Ligands and Practical Issues in Preclinical PET Research
Technetium-99M Radiopharmaceuticals: Status and Trends
Radiopharmacy: an Update
Altanserin Binding: a Pilot PET Study in Humans
Dr. Bertrand Tavitian Dr. Andreas Jacobs Dr. Gitte Moos Knudsen Dr
[ C]-DASB Binding to the Human Serotonin Transporter
Radiopharmaceutical Therapy in Cancer: Clinical Advances and Challenges
Effects of Reduced Endogenous 5-HT on the in Vivo Binding of the Serotonin Transporter Radioligand 11C-DASB in Healthy Humans
Synthesis, Characterization and Biological Studies of Technetium-99M and Rhenium-188 Peptides
PSMA Theranostics: Current Landscape and Future Outlook
Toward Noninvasive Quantification of Brain Radioligand Binding by Combining Electronic Health 1273
Current Directions in Radiopharmaceutical Research
11C-NS14492 As a Novel PET Radioligand for Imaging Cerebral A7 Nicotinic Acetylcholine Receptors: in Vivo Evaluation and Drug Occupancy Measurements
Neuroinflammation PET Imaging: Current Opinion and Future Directions
PET Quantification of 5-Ht2areceptors in the Human Brain: a Constant Infusion Paradigm with [1 8F]Altanserin
Presynaptic 5-HT1A Is Related to 5-HTT Receptor Density in the Human Brain